Auteurs
Paul England

Paul England, DPhil

Senior professional support lawyer

Read More
Rhys Bufton

Rhys Bufton

Collaborateur senior

Read More
Auteurs
Paul England

Paul England, DPhil

Senior professional support lawyer

Read More
Rhys Bufton

Rhys Bufton

Collaborateur senior

Read More

1 juin 2018

Synapse - law for life sciences - May 2018

This month on Synapse

Blockchain technology in the life sciences and healthcare industries

Alex Walker explains what block chain technology is and how the life sciences and healthcare industries stand to benefit from it.

Topical issues

Choosing the right space for life science success

Raman Sharma, Rhys Bufton and Lucy Sharples discuss how to choose among the various letting strategies available in the life sciences space.

GC finds Normon similar to Normosang for pharmaceuticals

The General Court has upheld a decision of the Board of Appeal that the marks Normon and Normosang, both covering pharmaceutical products, are confusingly similar.

AG's Opinion on how a product must be identified by a patent for SPC protection

Paul England brings news of the latest SPC development, the Ag's Opinion on whether or not Truvada (a combination of tenofovir disoproxil and emtricitabine) is protected by a patent claiming tenofovir disoproxil and ̔optionally other therapeutic ingredients.

The UK has ratified the UPC Agreement

After delay, the UK has ratified the UPC Agreement. What next?

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Sciences de la vie et Santé

Synapse - December 2019

19 décembre 2019

par plusieurs auteurs

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Cannabis: what's new for the 6000 year old medicine?

8 novembre 2018

par Paul England, DPhil

Cliquer ici pour en savoir plus